NASDAQ:MDLN Medline (MDLN) Stock Price, News & Analysis $37.68 -1.49 (-3.80%) Closing price 11/17/2026 04:00 PM EasternExtended Trading$37.55 -0.13 (-0.34%) As of 11/17/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Medline Stock (NASDAQ:MDLN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Medline alerts:Sign Up Key Stats Today's Range$37.56▼$39.4550-Day Range$31.64▼$42.1652-Week Range$31.37▼$50.88Volume9.07 million shsAverage Volume10.96 million shsMarket Capitalization$49.56 billionP/E Ratio32.37Dividend YieldN/APrice Target$46.08Consensus RatingModerate Buy Company Overview Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations. The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations. Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally. The company was built as a family business and has grown into a major supplier to the healthcare industry.AI Generated. May Contain Errors. Read More Medline Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks76th Percentile Overall ScoreMDLN MarketRank™: 3.79473194093 of 5 starsMedline scored higher than 76% of companies evaluated by MarketBeat, and ranked 253rd out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingMedline has received a consensus rating of Moderate Buy. The company's average rating score is 2.72, and is based on no strong buy ratings, 23 buy ratings, 4 hold ratings, and 2 sell ratings.Upside PotentialMedline has a consensus price target of $46.08, representing about 22.3% upside from its current price of $37.68.Amount of Analyst CoverageMedline has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Medline's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-8.23% Earnings GrowthEarnings for Medline are expected to decrease by -8.23% in the coming year, from $1.58 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medline is 32.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Medline is 32.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.76.Price to Earnings Growth RatioMedline has a PEG Ratio of 4.36. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedline has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.90% of the float of Medline has been sold short.Short Interest Ratio / Days to CoverMedline has a short interest ratio ("days to cover") of 3.79, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medline has recently decreased by 7.29%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMedline does not currently pay a dividend.Dividend GrowthMedline does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.89 News SentimentMedline has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Medline this week, compared to 9 articles on an average week.Search InterestOnly 9 people have searched for MDLN on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Medline to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Medline insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $224,525,137.00 in company stock.Percentage Held by Insiders0.81% of the stock of Medline is held by insiders.Percentage Held by InstitutionsMedline has minimal institutional ownership at this time.Read more about Medline's insider trading history. Receive MDLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medline and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDLN Stock News HeadlinesMedline Prices Secondary Offering Of 60 Mln Class A Shares At $35.50 Per Share1 hour ago | rttnews.comMedline prices 60M share secondary offering at $35.50/share alongside $200M concurrent repurchase1 hour ago | seekingalpha.comMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year. | Profits Run (Ad)Medline Announces Pricing of Secondary Offering of 60 Million Shares by Selling Stockholders and $200 Million Share Repurchase 3 hours ago | quiverquant.comQMedline Inc. announces pricing of secondary offering of Class A common stock3 hours ago | globenewswire.comMedline (NASDAQ:MDLN) Stock Breaks Below 200-Day Moving Average - Here's What HappenedNovember 17 at 3:13 AM | americanbankingnews.comValueAct buys Agilent, exits Roblox, reduces Toast among Q3 movesNovember 16 at 6:57 PM | msn.comMedline Announces Secondary Public Offering of 60 Million Shares and $200 Million Share Repurchase TransactionNovember 16 at 7:11 AM | quiverquant.comQSee More Headlines MDLN Stock Analysis - Frequently Asked Questions How have MDLN shares performed this year? Medline's stock was trading at $42.00 on January 1st, 2026. Since then, MDLN stock has decreased by 10.3% and is now trading at $37.68. How were Medline's earnings last quarter? Medline (NASDAQ:MDLN) announced its quarterly earnings results on Wednesday, November, 4th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.12. The firm had revenue of $7.86 billion for the quarter. Medline had a trailing twelve-month return on equity of 8.21% and a net margin of 1.84%. Read the conference call transcript. When did Medline IPO? Medline (MDLN) raised $7 billion in an IPO on Wednesday, December 17th 2025. The company issued 248,439,654 shares at a price of $26.00-$30.00 per share. Who are Medline's major shareholders? Top institutional investors of Medline include State Street Corp (0.75%), Banque Pictet & Cie SA (0.57%), Healthcare of Ontario Pension Plan Trust Fund (0.53%) and Durable Capital Partners LP (0.36%). Insiders that own company stock include Group Vii S1 LLC Tc, Aggregator Lp Mozart II, Cp Circle Ml Holdco Gp, Llc, Carlyle Group Inc, Mozart Coinvestment Ho Carlyle, Tc Group Cayman Investment Hol, Private Ltd Gic, Andrew J Mills, Charles N Mills, Hellman & Friedman Capital Par, Douglas P Golwas and Jessi L Corcoran. View institutional ownership trends. How do I buy shares of Medline? Shares of MDLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medline own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medline investors own include NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Oracle (ORCL), Broadcom (AVGO), Micron Technology (MU) and Netflix (NFLX). Company Calendar Last Earnings11/04/2026Today11/17/2026Jefferies Global Healthcare Conference11/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNASDAQ:MDLN CIK2046386 Webwww.medline.com Phone(847) 949-3000FaxN/AEmployees45,000Year Founded1966Price Target and Rating Average Price Target for Medline$46.08 High Price Target$55.00 Low Price Target$34.00 Potential Upside/Downside+22.3%Consensus RatingModerate Buy Rating Score (0-4)2.72 Research Coverage29 Analysts Profitability EPS (Trailing Twelve Months)$0.44 Trailing P/E Ratio32.37 Forward P/E Ratio25.99 P/E Growth4.36Net Income$1.16 billion Net Margins1.84% Pretax Margin3.64% Return on Equity8.21% Return on Assets4.03% Debt Debt-to-Equity Ratio0.65 Current Ratio4.04 Quick Ratio2.51 Sales & Book Value Annual Sales$28.43 billion Price / Sales1.74 Cash Flow$1.63 per share Price / Cash Flow23.09 Book Value$14.74 per share Price / Book2.56Miscellaneous Outstanding Shares1,315,320,000Free Float1,304,667,000Market Cap$49.56 billion OptionableOptionable BetaN/A Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:MDLN) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredAmerica's Biggest Bank… Down?About 4,800 Chase customers reported problems in just 15 minutes on Monday. Many couldn't log in or move money...Decentralized Masters | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medline Please log in to your account or sign up in order to add this asset to your watchlist. Share Medline With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.